These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 89059)

  • 1. Does OK-432 selectively increase bleomycin concentration in tumor?
    Okuyama S; Mishina H; Matsuzawa T
    Gan; 1979 Jun; 70(3):385-6. PubMed ID: 89059
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased tumor uptake of 67Ga citrate following a course of picibanil (NSC-B116209).
    Okuyama S; Mishina H; Matsuzawa T
    Sci Rep Res Inst Tohoku Univ Med; 1979 Sep; 26(1-2):18-21. PubMed ID: 515724
    [No Abstract]   [Full Text] [Related]  

  • 3. [Basic studies on the effects of oral administration of streptococcal preparation OK-432. I. Effects of thoracic duct lymphocytes].
    Hanaue H; Kurosawa T; Nemoto A; Asagoe T; Shikata J
    Nihon Gan Chiryo Gakkai Shi; 1987 Aug; 22(7):1348-53. PubMed ID: 3501454
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of streptococcal preparation OK-432 on chemically-induced intestinal carcinoma in rats.
    Ichihashi H; Kuzuya H; Kondo T
    Nagoya J Med Sci; 1980 Mar; 42(3-4):49-54. PubMed ID: 7383144
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of azathiopurine and OK-432 on urinary bladder carcinogenesis in rats.
    Cohen SM; Fukushima S; Tsuda H; Murasaki G; Ito N
    Gan; 1978 Dec; 69(6):773-9. PubMed ID: 750272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Induction of tumor necrosis factor (TNF) by OK-432].
    Watanabe N; Sone H; Neda H; Niitsu Y; Urushizaki I
    Gan No Rinsho; 1984 Aug; 30(10):1290-2. PubMed ID: 6481965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of OK-432 on UFT activation].
    Yamamoto Y; Amano T; Imada T; Tamura S; Abe M; Matsumoto A
    Gan No Rinsho; 1988 May; 34(6):749-54. PubMed ID: 3132564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of a Streptococcus pyogenes preparation (OK-432). I. Sequential effector mechanisms following a single OK-432 injection in F344 rats leading to the rejection of syngeneic MADB106 tumor cells.
    Fukui H; Reynolds CW
    J Natl Cancer Inst; 1987 Nov; 79(5):1011-7. PubMed ID: 3479632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic cells induced in tumor-bearing rats by a streptococcus preparation (OK-432).
    Hojo H; Hashimoto Y
    Gan; 1981 Oct; 72(5):692-9. PubMed ID: 7327369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synergistic activation of rat alveolar macrophages by cepharanthine and OK-432].
    Morioka S; Ono M; Tanaka N; Orita K
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1470-5. PubMed ID: 4015121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consecutive, multimodal therapy of cancer: selective biological initiation (OK-432), cytoplasmic and nuclear damage (FT-207 and cyclophosphamide), inhibition of repair (bleomycin), and activation of cleansing and surveillance mechanisms.
    Okuyama S; Mishina H
    Sci Rep Res Inst Tohoku Univ Med; 1981 Dec; 28(1-4):7-14. PubMed ID: 6179159
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitumor activity of a Streptococcus pyogenes preparation (OK-432). II. Analysis of the cytotoxic lymphocytes induced by OK-432 injection into tumor-bearing F344 rats.
    Fukui H; Reynolds CW
    J Natl Cancer Inst; 1987 Nov; 79(5):1019-24. PubMed ID: 3500354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor effect of a streptococcal preparation (OK-432). 1. Positive co-relation between the anti-tumour effect and delayed type hypersensitivity reaction to OK-432 in mice.
    Makidono R; Matsuura K; Makidono A
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Feb; 44(2):379-91. PubMed ID: 6477682
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of a streptococcal preparation, OK-432, on murine hematopoietic stem cells.
    Hiraoka A; Yamagishi M; Ohkubo T; Yoshida Y; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1981 Jul; 44(4):860-3. PubMed ID: 6977253
    [No Abstract]   [Full Text] [Related]  

  • 15. [A basic study of combination cancer immunotherapy with OK-432 and rIL-2--induction of lymphokine-activated killer (LAK) precursor cells in murine spleen by intravenous administration of OK-432].
    Shimoda K; Saito T; Kobayashi M
    Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1566-73. PubMed ID: 3263451
    [No Abstract]   [Full Text] [Related]  

  • 16. [Successful adoptive immunotherapy with OK432-inducible activated natural killer cells on tumor-bearing mice].
    Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K
    Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2546-55. PubMed ID: 2614190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of OK-432 on the concentration of active substance of fluoropyrimidine carcinostatics in the living body].
    Okamoto Y; Nakamura A; Ohkawa T
    Nihon Gan Chiryo Gakkai Shi; 1986 May; 21(4):780-5. PubMed ID: 3093612
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of macrophage tumoricidal activity by a serum glycoprotein that increased in OK-432-treated mice.
    Torikai T; Itoh O; Satoh M; Osawa T
    Gan; 1980 Feb; 71(1):52-9. PubMed ID: 7380137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral administration of OK-432 (picibanil). (8th report) clinical application: its immunomodulatory effects on the patients with gastrointestinal cancers].
    Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1607-15. PubMed ID: 2809385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of OK-432 on activated lysozyme in monocytes and neutrophils --comparison of intravenous and intramuscular administrations].
    Fujii M; Okabe K; Tamai M; Toki H
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):383-4. PubMed ID: 3970558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.